OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
Johan Sundström, Robin Kristófi, Ollie Östlund, et al.
Journal of Diabetes and its Complications (2021) Vol. 35, Iss. 10, pp. 107996-107996
Open Access | Times Cited: 12
Johan Sundström, Robin Kristófi, Ollie Östlund, et al.
Journal of Diabetes and its Complications (2021) Vol. 35, Iss. 10, pp. 107996-107996
Open Access | Times Cited: 12
Showing 12 citing articles:
Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors Versus Metformin
HoJin Shin, Sebastian Schneeweiß, Robert J. Glynn, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 7, pp. 927-937
Closed Access | Times Cited: 34
HoJin Shin, Sebastian Schneeweiß, Robert J. Glynn, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 7, pp. 927-937
Closed Access | Times Cited: 34
Metformin: evidence from preclinical and clinical studies for potential novel applications in cardiovascular disease
Adel Dihoum, Graham Rena, Ewan R. Pearson, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 4, pp. 291-299
Open Access | Times Cited: 15
Adel Dihoum, Graham Rena, Ewan R. Pearson, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 4, pp. 291-299
Open Access | Times Cited: 15
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions
Alfredo Caturano, Erica Vetrano, Raffaele Galiero, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10173-10173
Open Access | Times Cited: 4
Alfredo Caturano, Erica Vetrano, Raffaele Galiero, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 10173-10173
Open Access | Times Cited: 4
3. BLOOD GLUCOSE-LOWERING THERAPIES – NON-INSULIN OPTIONS FOR TYPE 2 DIABETES
Stephen Colagiuri, Antonio Ceriello
Diabetes Research and Clinical Practice (2025), pp. 112147-112147
Closed Access
Stephen Colagiuri, Antonio Ceriello
Diabetes Research and Clinical Practice (2025), pp. 112147-112147
Closed Access
Effect of metformin on adverse outcomes in T2DM patients: Systemic review and meta-analysis of observational studies
Zhicheng Xu, Haidong Zhang, Chenghui Wu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Zhicheng Xu, Haidong Zhang, Chenghui Wu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Health care registers can be instrumental for endpoint capture in clinical diabetes trials: example of microvascular complications in Swedish patients with type 2 diabetes
M. Lundqvist, Vagia Patsoukaki, Stefan Jansson, et al.
Diabetes and Vascular Disease Research (2023) Vol. 20, Iss. 3
Open Access | Times Cited: 3
M. Lundqvist, Vagia Patsoukaki, Stefan Jansson, et al.
Diabetes and Vascular Disease Research (2023) Vol. 20, Iss. 3
Open Access | Times Cited: 3
Evolving channeling in prescribing SGLT ‐2 inhibitors as first‐line treatment for type 2 diabetes
HoJin Shin, Sebastian Schneeweiß, Robert J. Glynn, et al.
Pharmacoepidemiology and Drug Safety (2022) Vol. 31, Iss. 5, pp. 566-576
Open Access | Times Cited: 4
HoJin Shin, Sebastian Schneeweiß, Robert J. Glynn, et al.
Pharmacoepidemiology and Drug Safety (2022) Vol. 31, Iss. 5, pp. 566-576
Open Access | Times Cited: 4
Registry-based randomised clinical trials: a remedy for evidence-based diabetes care?
Jan W. Eriksson, Björn Eliasson, Louise Bennet, et al.
Diabetologia (2022) Vol. 65, Iss. 10, pp. 1575-1586
Open Access | Times Cited: 3
Jan W. Eriksson, Björn Eliasson, Louise Bennet, et al.
Diabetologia (2022) Vol. 65, Iss. 10, pp. 1575-1586
Open Access | Times Cited: 3
“I mean, we live on an island and need to be self-sufficient, even with research” Patients' and healthcare professionals' views on participation in clinical studies in primary health care in a sparsely populated region: a qualitative study (Preprint)
Janeth Leksell
(2024)
Open Access
Janeth Leksell
(2024)
Open Access
Knowledge and practice of community pharmacists towards SGLT2 inhibitors
Abdelrahim Alqudah, Muna Oqal, Ahmed Mohammad Al‐Smadi, et al.
F1000Research (2022) Vol. 11, pp. 659-659
Open Access
Abdelrahim Alqudah, Muna Oqal, Ahmed Mohammad Al‐Smadi, et al.
F1000Research (2022) Vol. 11, pp. 659-659
Open Access
Knowledge and practice of community pharmacists towards SGLT2 inhibitors
Abdelrahim Alqudah, Muna Oqal, Ahmed Mohammad Al‐Smadi, et al.
F1000Research (2022) Vol. 11, pp. 659-659
Open Access
Abdelrahim Alqudah, Muna Oqal, Ahmed Mohammad Al‐Smadi, et al.
F1000Research (2022) Vol. 11, pp. 659-659
Open Access
